nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoniazid—CYP2D6—Temsirolimus—kidney cancer	0.0606	0.0869	CbGbCtD
Isoniazid—CYP3A4—Everolimus—kidney cancer	0.0571	0.0818	CbGbCtD
Isoniazid—CYP2C8—Pazopanib—kidney cancer	0.0499	0.0716	CbGbCtD
Isoniazid—CYP1A2—Pazopanib—kidney cancer	0.0387	0.0554	CbGbCtD
Isoniazid—CYP3A4—Temsirolimus—kidney cancer	0.0386	0.0553	CbGbCtD
Isoniazid—CYP2C9—Capecitabine—kidney cancer	0.0363	0.0521	CbGbCtD
Isoniazid—CYP2C8—Erlotinib—kidney cancer	0.0356	0.0511	CbGbCtD
Isoniazid—CYP2C8—Paclitaxel—kidney cancer	0.0326	0.0468	CbGbCtD
Isoniazid—CYP2D6—Pazopanib—kidney cancer	0.0319	0.0457	CbGbCtD
Isoniazid—NAT2—urine—kidney cancer	0.0303	0.395	CbGeAlD
Isoniazid—CYP2C8—Sorafenib—kidney cancer	0.029	0.0415	CbGbCtD
Isoniazid—CYP1A2—Erlotinib—kidney cancer	0.0276	0.0395	CbGbCtD
Isoniazid—CYP2C19—Sorafenib—kidney cancer	0.0243	0.0348	CbGbCtD
Isoniazid—CYP2C9—Paclitaxel—kidney cancer	0.0228	0.0326	CbGbCtD
Isoniazid—CYP2D6—Erlotinib—kidney cancer	0.0227	0.0326	CbGbCtD
Isoniazid—CYP1A2—Sorafenib—kidney cancer	0.0224	0.0322	CbGbCtD
Isoniazid—CYP3A4—Pazopanib—kidney cancer	0.0203	0.029	CbGbCtD
Isoniazid—CYP2C9—Sorafenib—kidney cancer	0.0202	0.029	CbGbCtD
Isoniazid—CYP2D6—Sorafenib—kidney cancer	0.0185	0.0265	CbGbCtD
Isoniazid—CYP2D6—Vinblastine—kidney cancer	0.0182	0.0262	CbGbCtD
Isoniazid—CYP3A4—Erlotinib—kidney cancer	0.0145	0.0207	CbGbCtD
Isoniazid—CYP3A4—Paclitaxel—kidney cancer	0.0132	0.019	CbGbCtD
Isoniazid—CYP3A4—Sorafenib—kidney cancer	0.0118	0.0168	CbGbCtD
Isoniazid—CYP3A4—Vinblastine—kidney cancer	0.0116	0.0166	CbGbCtD
Isoniazid—CYP3A4—Vincristine—kidney cancer	0.0114	0.0164	CbGbCtD
Isoniazid—CYP2D6—Doxorubicin—kidney cancer	0.0112	0.0161	CbGbCtD
Isoniazid—CYP3A4—Sunitinib—kidney cancer	0.00952	0.0136	CbGbCtD
Isoniazid—NAT2—renal system—kidney cancer	0.00743	0.0967	CbGeAlD
Isoniazid—CYP3A4—Doxorubicin—kidney cancer	0.00713	0.0102	CbGbCtD
Isoniazid—CYP2C19—urine—kidney cancer	0.00609	0.0793	CbGeAlD
Isoniazid—CYP1A2—urine—kidney cancer	0.00497	0.0648	CbGeAlD
Isoniazid—CYP2C9—urine—kidney cancer	0.00472	0.0615	CbGeAlD
Isoniazid—CYP2E1—urine—kidney cancer	0.00447	0.0583	CbGeAlD
Isoniazid—CYP3A4—urine—kidney cancer	0.0036	0.0469	CbGeAlD
Isoniazid—CYP2D6—urine—kidney cancer	0.00354	0.0461	CbGeAlD
Isoniazid—Systemic lupus erythematosus—Paclitaxel—kidney cancer	0.00174	0.0114	CcSEcCtD
Isoniazid—Hepatocellular injury—Everolimus—kidney cancer	0.00171	0.0113	CcSEcCtD
Isoniazid—Hepatocellular injury—Erlotinib—kidney cancer	0.00165	0.0109	CcSEcCtD
Isoniazid—Neuritis—Vincristine—kidney cancer	0.00162	0.0107	CcSEcCtD
Isoniazid—Neuritis—Gemcitabine—kidney cancer	0.00154	0.0101	CcSEcCtD
Isoniazid—Lymphadenopathy—Everolimus—kidney cancer	0.00146	0.00958	CcSEcCtD
Isoniazid—Diabetes mellitus—Everolimus—kidney cancer	0.00143	0.00939	CcSEcCtD
Isoniazid—Gynaecomastia—Sorafenib—kidney cancer	0.00133	0.00874	CcSEcCtD
Isoniazid—Neurotoxicity—Doxorubicin—kidney cancer	0.00131	0.00862	CcSEcCtD
Isoniazid—Hyperglycaemia—Temsirolimus—kidney cancer	0.0013	0.00856	CcSEcCtD
Isoniazid—CYP2C8—renal system—kidney cancer	0.0013	0.0169	CbGeAlD
Isoniazid—Neuritis—Paclitaxel—kidney cancer	0.00129	0.00846	CcSEcCtD
Isoniazid—Aplastic anaemia—Dactinomycin—kidney cancer	0.00127	0.00836	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Gemcitabine—kidney cancer	0.00126	0.0083	CcSEcCtD
Isoniazid—CYP2C8—kidney—kidney cancer	0.00126	0.0164	CbGeAlD
Isoniazid—Hepatic function abnormal—Sorafenib—kidney cancer	0.00124	0.00812	CcSEcCtD
Isoniazid—CYP1A2—renal system—kidney cancer	0.00122	0.0159	CbGeAlD
Isoniazid—CYP2E1—nephron tubule—kidney cancer	0.0012	0.0157	CbGeAlD
Isoniazid—Hepatic function abnormal—Sunitinib—kidney cancer	0.00119	0.00781	CcSEcCtD
Isoniazid—Jaundice—Pazopanib—kidney cancer	0.00118	0.00777	CcSEcCtD
Isoniazid—Vasculitis—Gemcitabine—kidney cancer	0.00118	0.00773	CcSEcCtD
Isoniazid—CYP2E1—renal system—kidney cancer	0.00109	0.0143	CbGeAlD
Isoniazid—CYP2E1—kidney—kidney cancer	0.00106	0.0138	CbGeAlD
Isoniazid—Hyperbilirubinaemia—Paclitaxel—kidney cancer	0.00106	0.00695	CcSEcCtD
Isoniazid—CYP2E1—cortex of kidney—kidney cancer	0.00103	0.0134	CbGeAlD
Isoniazid—Memory impairment—Capecitabine—kidney cancer	0.00101	0.0066	CcSEcCtD
Isoniazid—Hyperglycaemia—Everolimus—kidney cancer	0.00097	0.00637	CcSEcCtD
Isoniazid—Hepatic function abnormal—Gemcitabine—kidney cancer	0.000954	0.00627	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vinblastine—kidney cancer	0.000943	0.0062	CcSEcCtD
Isoniazid—Jaundice—Everolimus—kidney cancer	0.000935	0.00614	CcSEcCtD
Isoniazid—Neuropathy peripheral—Erlotinib—kidney cancer	0.000907	0.00596	CcSEcCtD
Isoniazid—Agranulocytosis—Vinblastine—kidney cancer	0.000898	0.0059	CcSEcCtD
Isoniazid—CYP3A4—renal system—kidney cancer	0.000881	0.0115	CbGeAlD
Isoniazid—Convulsion—Temsirolimus—kidney cancer	0.000873	0.00573	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Capecitabine—kidney cancer	0.000868	0.0057	CcSEcCtD
Isoniazid—CYP2D6—renal system—kidney cancer	0.000867	0.0113	CbGeAlD
Isoniazid—Hepatitis—Everolimus—kidney cancer	0.000861	0.00565	CcSEcCtD
Isoniazid—CYP3A4—kidney—kidney cancer	0.000851	0.0111	CbGeAlD
Isoniazid—CYP2D6—kidney—kidney cancer	0.000838	0.0109	CbGeAlD
Isoniazid—Hepatitis—Erlotinib—kidney cancer	0.00083	0.00545	CcSEcCtD
Isoniazid—Eruption—Doxorubicin—kidney cancer	0.000827	0.00543	CcSEcCtD
Isoniazid—Optic neuritis—Doxorubicin—kidney cancer	0.000827	0.00543	CcSEcCtD
Isoniazid—Neuropathy peripheral—Sorafenib—kidney cancer	0.000816	0.00536	CcSEcCtD
Isoniazid—Jaundice—Sorafenib—kidney cancer	0.000811	0.00533	CcSEcCtD
Isoniazid—Hyperglycaemia—Sunitinib—kidney cancer	0.00081	0.00532	CcSEcCtD
Isoniazid—Thrombocytopenia—Temsirolimus—kidney cancer	0.000805	0.00529	CcSEcCtD
Isoniazid—Neuropathy peripheral—Sunitinib—kidney cancer	0.000785	0.00516	CcSEcCtD
Isoniazid—Anorexia—Temsirolimus—kidney cancer	0.000784	0.00515	CcSEcCtD
Isoniazid—Thrombocytopenia—Pazopanib—kidney cancer	0.000758	0.00498	CcSEcCtD
Isoniazid—Anorexia—Pazopanib—kidney cancer	0.000738	0.00485	CcSEcCtD
Isoniazid—Hepatitis—Sunitinib—kidney cancer	0.000719	0.00472	CcSEcCtD
Isoniazid—Decreased appetite—Temsirolimus—kidney cancer	0.000715	0.00469	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Temsirolimus—kidney cancer	0.00071	0.00466	CcSEcCtD
Isoniazid—Fatigue—Temsirolimus—kidney cancer	0.000709	0.00465	CcSEcCtD
Isoniazid—Agranulocytosis—Dactinomycin—kidney cancer	0.000708	0.00465	CcSEcCtD
Isoniazid—Ill-defined disorder—Vinblastine—kidney cancer	0.000698	0.00458	CcSEcCtD
Isoniazid—Paraesthesia—Pazopanib—kidney cancer	0.000695	0.00457	CcSEcCtD
Isoniazid—Ill-defined disorder—Everolimus—kidney cancer	0.000695	0.00457	CcSEcCtD
Isoniazid—Dyspepsia—Pazopanib—kidney cancer	0.000682	0.00448	CcSEcCtD
Isoniazid—Neuritis—Doxorubicin—kidney cancer	0.000681	0.00448	CcSEcCtD
Isoniazid—Hepatitis—Dactinomycin—kidney cancer	0.000681	0.00447	CcSEcCtD
Isoniazid—Malaise—Vinblastine—kidney cancer	0.000678	0.00445	CcSEcCtD
Isoniazid—Malaise—Everolimus—kidney cancer	0.000676	0.00444	CcSEcCtD
Isoniazid—Decreased appetite—Pazopanib—kidney cancer	0.000673	0.00442	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Pazopanib—kidney cancer	0.000669	0.00439	CcSEcCtD
Isoniazid—Fatigue—Pazopanib—kidney cancer	0.000668	0.00439	CcSEcCtD
Isoniazid—Neuropathy peripheral—Vincristine—kidney cancer	0.000664	0.00436	CcSEcCtD
Isoniazid—Diabetes mellitus—Capecitabine—kidney cancer	0.000659	0.00433	CcSEcCtD
Isoniazid—Hepatic function abnormal—Capecitabine—kidney cancer	0.000656	0.00431	CcSEcCtD
Isoniazid—Convulsion—Vinblastine—kidney cancer	0.000652	0.00428	CcSEcCtD
Isoniazid—Hyperglycaemia—Gemcitabine—kidney cancer	0.00065	0.00427	CcSEcCtD
Isoniazid—Body temperature increased—Temsirolimus—kidney cancer	0.00065	0.00427	CcSEcCtD
Isoniazid—Convulsion—Everolimus—kidney cancer	0.000649	0.00426	CcSEcCtD
Isoniazid—Discomfort—Vinblastine—kidney cancer	0.000633	0.00415	CcSEcCtD
Isoniazid—Discomfort—Everolimus—kidney cancer	0.00063	0.00414	CcSEcCtD
Isoniazid—Neuropathy peripheral—Gemcitabine—kidney cancer	0.00063	0.00414	CcSEcCtD
Isoniazid—Hypersensitivity—Temsirolimus—kidney cancer	0.000606	0.00398	CcSEcCtD
Isoniazid—Liver injury—Doxorubicin—kidney cancer	0.000605	0.00397	CcSEcCtD
Isoniazid—Thrombocytopenia—Vinblastine—kidney cancer	0.000601	0.00395	CcSEcCtD
Isoniazid—Agranulocytosis—Gemcitabine—kidney cancer	0.0006	0.00394	CcSEcCtD
Isoniazid—Thrombocytopenia—Everolimus—kidney cancer	0.000599	0.00393	CcSEcCtD
Isoniazid—Asthenia—Temsirolimus—kidney cancer	0.00059	0.00387	CcSEcCtD
Isoniazid—Anorexia—Vinblastine—kidney cancer	0.000585	0.00384	CcSEcCtD
Isoniazid—Anorexia—Everolimus—kidney cancer	0.000583	0.00383	CcSEcCtD
Isoniazid—Thrombocytopenia—Erlotinib—kidney cancer	0.000578	0.00379	CcSEcCtD
Isoniazid—Anorexia—Erlotinib—kidney cancer	0.000562	0.00369	CcSEcCtD
Isoniazid—Hyperbilirubinaemia—Doxorubicin—kidney cancer	0.000559	0.00367	CcSEcCtD
Isoniazid—Asthenia—Pazopanib—kidney cancer	0.000556	0.00365	CcSEcCtD
Isoniazid—Paraesthesia—Vinblastine—kidney cancer	0.000551	0.00362	CcSEcCtD
Isoniazid—Ill-defined disorder—Dactinomycin—kidney cancer	0.00055	0.00361	CcSEcCtD
Isoniazid—Paraesthesia—Everolimus—kidney cancer	0.000549	0.00361	CcSEcCtD
Isoniazid—Hyperglycaemia—Paclitaxel—kidney cancer	0.000544	0.00357	CcSEcCtD
Isoniazid—Convulsion—Sunitinib—kidney cancer	0.000542	0.00356	CcSEcCtD
Isoniazid—Dyspepsia—Everolimus—kidney cancer	0.000538	0.00354	CcSEcCtD
Isoniazid—Malaise—Dactinomycin—kidney cancer	0.000534	0.00351	CcSEcCtD
Isoniazid—Decreased appetite—Vinblastine—kidney cancer	0.000534	0.0035	CcSEcCtD
Isoniazid—Decreased appetite—Everolimus—kidney cancer	0.000532	0.00349	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Everolimus—kidney cancer	0.000528	0.00347	CcSEcCtD
Isoniazid—Neuropathy peripheral—Paclitaxel—kidney cancer	0.000527	0.00346	CcSEcCtD
Isoniazid—Fatigue—Everolimus—kidney cancer	0.000527	0.00346	CcSEcCtD
Isoniazid—Vomiting—Temsirolimus—kidney cancer	0.000523	0.00343	CcSEcCtD
Isoniazid—Thrombocytopenia—Sorafenib—kidney cancer	0.00052	0.00341	CcSEcCtD
Isoniazid—Dyspepsia—Erlotinib—kidney cancer	0.000519	0.00341	CcSEcCtD
Isoniazid—Rash—Temsirolimus—kidney cancer	0.000518	0.0034	CcSEcCtD
Isoniazid—Decreased appetite—Erlotinib—kidney cancer	0.000513	0.00337	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000509	0.00335	CcSEcCtD
Isoniazid—Hepatocellular injury—Doxorubicin—kidney cancer	0.000509	0.00334	CcSEcCtD
Isoniazid—Fatigue—Erlotinib—kidney cancer	0.000509	0.00334	CcSEcCtD
Isoniazid—Anorexia—Sorafenib—kidney cancer	0.000506	0.00332	CcSEcCtD
Isoniazid—Feeling abnormal—Vinblastine—kidney cancer	0.000506	0.00332	CcSEcCtD
Isoniazid—Feeling abnormal—Everolimus—kidney cancer	0.000504	0.00331	CcSEcCtD
Isoniazid—Thrombocytopenia—Sunitinib—kidney cancer	0.0005	0.00328	CcSEcCtD
Isoniazid—Discomfort—Dactinomycin—kidney cancer	0.000498	0.00327	CcSEcCtD
Isoniazid—Vomiting—Pazopanib—kidney cancer	0.000492	0.00323	CcSEcCtD
Isoniazid—Rash—Pazopanib—kidney cancer	0.000488	0.00321	CcSEcCtD
Isoniazid—Nausea—Temsirolimus—kidney cancer	0.000488	0.00321	CcSEcCtD
Isoniazid—Anorexia—Sunitinib—kidney cancer	0.000487	0.0032	CcSEcCtD
Isoniazid—Body temperature increased—Everolimus—kidney cancer	0.000483	0.00317	CcSEcCtD
Isoniazid—Aplastic anaemia—Doxorubicin—kidney cancer	0.000478	0.00314	CcSEcCtD
Isoniazid—Thrombocytopenia—Dactinomycin—kidney cancer	0.000473	0.00311	CcSEcCtD
Isoniazid—Dyspepsia—Sorafenib—kidney cancer	0.000467	0.00307	CcSEcCtD
Isoniazid—Body temperature increased—Erlotinib—kidney cancer	0.000466	0.00306	CcSEcCtD
Isoniazid—Ill-defined disorder—Gemcitabine—kidney cancer	0.000466	0.00306	CcSEcCtD
Isoniazid—Decreased appetite—Sorafenib—kidney cancer	0.000461	0.00303	CcSEcCtD
Isoniazid—Anorexia—Dactinomycin—kidney cancer	0.000461	0.00303	CcSEcCtD
Isoniazid—Nausea—Pazopanib—kidney cancer	0.00046	0.00302	CcSEcCtD
Isoniazid—Paraesthesia—Sunitinib—kidney cancer	0.000459	0.00301	CcSEcCtD
Isoniazid—Convulsion—Vincristine—kidney cancer	0.000459	0.00301	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000458	0.00301	CcSEcCtD
Isoniazid—Fatigue—Sorafenib—kidney cancer	0.000458	0.00301	CcSEcCtD
Isoniazid—Malaise—Gemcitabine—kidney cancer	0.000453	0.00297	CcSEcCtD
Isoniazid—Hypersensitivity—Vinblastine—kidney cancer	0.000452	0.00297	CcSEcCtD
Isoniazid—Hypersensitivity—Everolimus—kidney cancer	0.000451	0.00296	CcSEcCtD
Isoniazid—Dyspepsia—Sunitinib—kidney cancer	0.00045	0.00295	CcSEcCtD
Isoniazid—Hyperglycaemia—Capecitabine—kidney cancer	0.000447	0.00293	CcSEcCtD
Isoniazid—Decreased appetite—Sunitinib—kidney cancer	0.000444	0.00292	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000441	0.0029	CcSEcCtD
Isoniazid—Asthenia—Vinblastine—kidney cancer	0.00044	0.00289	CcSEcCtD
Isoniazid—Fatigue—Sunitinib—kidney cancer	0.00044	0.00289	CcSEcCtD
Isoniazid—Asthenia—Everolimus—kidney cancer	0.000439	0.00288	CcSEcCtD
Isoniazid—Lymphadenopathy—Doxorubicin—kidney cancer	0.000433	0.00284	CcSEcCtD
Isoniazid—Neuropathy peripheral—Capecitabine—kidney cancer	0.000433	0.00284	CcSEcCtD
Isoniazid—Jaundice—Capecitabine—kidney cancer	0.00043	0.00283	CcSEcCtD
Isoniazid—Diabetes mellitus—Doxorubicin—kidney cancer	0.000425	0.00279	CcSEcCtD
Isoniazid—Asthenia—Erlotinib—kidney cancer	0.000423	0.00278	CcSEcCtD
Isoniazid—Thrombocytopenia—Vincristine—kidney cancer	0.000423	0.00278	CcSEcCtD
Isoniazid—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000423	0.00278	CcSEcCtD
Isoniazid—Discomfort—Gemcitabine—kidney cancer	0.000422	0.00277	CcSEcCtD
Isoniazid—Decreased appetite—Dactinomycin—kidney cancer	0.00042	0.00276	CcSEcCtD
Isoniazid—Body temperature increased—Sorafenib—kidney cancer	0.00042	0.00276	CcSEcCtD
Isoniazid—Fatigue—Dactinomycin—kidney cancer	0.000417	0.00274	CcSEcCtD
Isoniazid—Agranulocytosis—Capecitabine—kidney cancer	0.000412	0.00271	CcSEcCtD
Isoniazid—Anorexia—Vincristine—kidney cancer	0.000412	0.0027	CcSEcCtD
Isoniazid—Body temperature increased—Sunitinib—kidney cancer	0.000404	0.00265	CcSEcCtD
Isoniazid—Thrombocytopenia—Gemcitabine—kidney cancer	0.000401	0.00264	CcSEcCtD
Isoniazid—Feeling abnormal—Dactinomycin—kidney cancer	0.000398	0.00262	CcSEcCtD
Isoniazid—Hepatitis—Capecitabine—kidney cancer	0.000396	0.0026	CcSEcCtD
Isoniazid—Hypersensitivity—Sorafenib—kidney cancer	0.000391	0.00257	CcSEcCtD
Isoniazid—Anorexia—Gemcitabine—kidney cancer	0.000391	0.00257	CcSEcCtD
Isoniazid—Vomiting—Vinblastine—kidney cancer	0.00039	0.00256	CcSEcCtD
Isoniazid—Ill-defined disorder—Paclitaxel—kidney cancer	0.00039	0.00256	CcSEcCtD
Isoniazid—Vomiting—Everolimus—kidney cancer	0.000389	0.00255	CcSEcCtD
Isoniazid—Paraesthesia—Vincristine—kidney cancer	0.000388	0.00255	CcSEcCtD
Isoniazid—Rash—Everolimus—kidney cancer	0.000386	0.00253	CcSEcCtD
Isoniazid—Body temperature increased—Dactinomycin—kidney cancer	0.000382	0.00251	CcSEcCtD
Isoniazid—Asthenia—Sorafenib—kidney cancer	0.000381	0.0025	CcSEcCtD
Isoniazid—Malaise—Paclitaxel—kidney cancer	0.000379	0.00249	CcSEcCtD
Isoniazid—Hypersensitivity—Sunitinib—kidney cancer	0.000376	0.00247	CcSEcCtD
Isoniazid—Decreased appetite—Vincristine—kidney cancer	0.000376	0.00247	CcSEcCtD
Isoniazid—Vomiting—Erlotinib—kidney cancer	0.000375	0.00246	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Vincristine—kidney cancer	0.000373	0.00245	CcSEcCtD
Isoniazid—Fatigue—Vincristine—kidney cancer	0.000372	0.00245	CcSEcCtD
Isoniazid—Rash—Erlotinib—kidney cancer	0.000372	0.00244	CcSEcCtD
Isoniazid—Paraesthesia—Gemcitabine—kidney cancer	0.000368	0.00242	CcSEcCtD
Isoniazid—Asthenia—Sunitinib—kidney cancer	0.000366	0.00241	CcSEcCtD
Isoniazid—Nausea—Vinblastine—kidney cancer	0.000365	0.00239	CcSEcCtD
Isoniazid—Convulsion—Paclitaxel—kidney cancer	0.000364	0.00239	CcSEcCtD
Isoniazid—Nausea—Everolimus—kidney cancer	0.000363	0.00239	CcSEcCtD
Isoniazid—Decreased appetite—Gemcitabine—kidney cancer	0.000356	0.00234	CcSEcCtD
Isoniazid—Hypersensitivity—Dactinomycin—kidney cancer	0.000356	0.00234	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000354	0.00232	CcSEcCtD
Isoniazid—Discomfort—Paclitaxel—kidney cancer	0.000354	0.00232	CcSEcCtD
Isoniazid—Fatigue—Gemcitabine—kidney cancer	0.000353	0.00232	CcSEcCtD
Isoniazid—Nausea—Erlotinib—kidney cancer	0.00035	0.0023	CcSEcCtD
Isoniazid—Asthenia—Dactinomycin—kidney cancer	0.000347	0.00228	CcSEcCtD
Isoniazid—Body temperature increased—Vincristine—kidney cancer	0.000342	0.00224	CcSEcCtD
Isoniazid—Feeling abnormal—Gemcitabine—kidney cancer	0.000338	0.00222	CcSEcCtD
Isoniazid—Vomiting—Sorafenib—kidney cancer	0.000337	0.00222	CcSEcCtD
Isoniazid—Thrombocytopenia—Paclitaxel—kidney cancer	0.000336	0.00221	CcSEcCtD
Isoniazid—Rash—Sorafenib—kidney cancer	0.000335	0.0022	CcSEcCtD
Isoniazid—Anorexia—Paclitaxel—kidney cancer	0.000327	0.00215	CcSEcCtD
Isoniazid—Vomiting—Sunitinib—kidney cancer	0.000325	0.00213	CcSEcCtD
Isoniazid—Body temperature increased—Gemcitabine—kidney cancer	0.000324	0.00213	CcSEcCtD
Isoniazid—Rash—Sunitinib—kidney cancer	0.000322	0.00211	CcSEcCtD
Isoniazid—Ill-defined disorder—Capecitabine—kidney cancer	0.00032	0.0021	CcSEcCtD
Isoniazid—Hypersensitivity—Vincristine—kidney cancer	0.000318	0.00209	CcSEcCtD
Isoniazid—Eosinophilia—Doxorubicin—kidney cancer	0.000316	0.00208	CcSEcCtD
Isoniazid—Nausea—Sorafenib—kidney cancer	0.000315	0.00207	CcSEcCtD
Isoniazid—Malaise—Capecitabine—kidney cancer	0.000311	0.00204	CcSEcCtD
Isoniazid—Asthenia—Vincristine—kidney cancer	0.00031	0.00204	CcSEcCtD
Isoniazid—Paraesthesia—Paclitaxel—kidney cancer	0.000308	0.00202	CcSEcCtD
Isoniazid—Vomiting—Dactinomycin—kidney cancer	0.000307	0.00202	CcSEcCtD
Isoniazid—Rash—Dactinomycin—kidney cancer	0.000305	0.002	CcSEcCtD
Isoniazid—Nausea—Sunitinib—kidney cancer	0.000303	0.00199	CcSEcCtD
Isoniazid—Dyspepsia—Paclitaxel—kidney cancer	0.000302	0.00198	CcSEcCtD
Isoniazid—Decreased appetite—Paclitaxel—kidney cancer	0.000298	0.00196	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000296	0.00195	CcSEcCtD
Isoniazid—Fatigue—Paclitaxel—kidney cancer	0.000296	0.00194	CcSEcCtD
Isoniazid—Asthenia—Gemcitabine—kidney cancer	0.000294	0.00193	CcSEcCtD
Isoniazid—Discomfort—Capecitabine—kidney cancer	0.00029	0.00191	CcSEcCtD
Isoniazid—Hyperglycaemia—Doxorubicin—kidney cancer	0.000288	0.00189	CcSEcCtD
Isoniazid—Nausea—Dactinomycin—kidney cancer	0.000287	0.00189	CcSEcCtD
Isoniazid—Feeling abnormal—Paclitaxel—kidney cancer	0.000283	0.00186	CcSEcCtD
Isoniazid—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000279	0.00183	CcSEcCtD
Isoniazid—Jaundice—Doxorubicin—kidney cancer	0.000277	0.00182	CcSEcCtD
Isoniazid—Thrombocytopenia—Capecitabine—kidney cancer	0.000276	0.00181	CcSEcCtD
Isoniazid—Vomiting—Vincristine—kidney cancer	0.000275	0.0018	CcSEcCtD
Isoniazid—Rash—Vincristine—kidney cancer	0.000272	0.00179	CcSEcCtD
Isoniazid—Body temperature increased—Paclitaxel—kidney cancer	0.000271	0.00178	CcSEcCtD
Isoniazid—Anorexia—Capecitabine—kidney cancer	0.000268	0.00176	CcSEcCtD
Isoniazid—Agranulocytosis—Doxorubicin—kidney cancer	0.000266	0.00174	CcSEcCtD
Isoniazid—Vomiting—Gemcitabine—kidney cancer	0.000261	0.00171	CcSEcCtD
Isoniazid—Rash—Gemcitabine—kidney cancer	0.000258	0.0017	CcSEcCtD
Isoniazid—Nausea—Vincristine—kidney cancer	0.000257	0.00169	CcSEcCtD
Isoniazid—Hepatitis—Doxorubicin—kidney cancer	0.000255	0.00168	CcSEcCtD
Isoniazid—Paraesthesia—Capecitabine—kidney cancer	0.000253	0.00166	CcSEcCtD
Isoniazid—Hypersensitivity—Paclitaxel—kidney cancer	0.000253	0.00166	CcSEcCtD
Isoniazid—Dyspepsia—Capecitabine—kidney cancer	0.000248	0.00163	CcSEcCtD
Isoniazid—Asthenia—Paclitaxel—kidney cancer	0.000246	0.00162	CcSEcCtD
Isoniazid—Decreased appetite—Capecitabine—kidney cancer	0.000245	0.00161	CcSEcCtD
Isoniazid—Nausea—Gemcitabine—kidney cancer	0.000243	0.0016	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000243	0.0016	CcSEcCtD
Isoniazid—Fatigue—Capecitabine—kidney cancer	0.000243	0.00159	CcSEcCtD
Isoniazid—Feeling abnormal—Capecitabine—kidney cancer	0.000232	0.00152	CcSEcCtD
Isoniazid—Body temperature increased—Capecitabine—kidney cancer	0.000223	0.00146	CcSEcCtD
Isoniazid—Vomiting—Paclitaxel—kidney cancer	0.000218	0.00143	CcSEcCtD
Isoniazid—Rash—Paclitaxel—kidney cancer	0.000216	0.00142	CcSEcCtD
Isoniazid—Hypersensitivity—Capecitabine—kidney cancer	0.000207	0.00136	CcSEcCtD
Isoniazid—Ill-defined disorder—Doxorubicin—kidney cancer	0.000206	0.00136	CcSEcCtD
Isoniazid—Nausea—Paclitaxel—kidney cancer	0.000204	0.00134	CcSEcCtD
Isoniazid—Asthenia—Capecitabine—kidney cancer	0.000202	0.00133	CcSEcCtD
Isoniazid—Malaise—Doxorubicin—kidney cancer	0.000201	0.00132	CcSEcCtD
Isoniazid—Convulsion—Doxorubicin—kidney cancer	0.000193	0.00127	CcSEcCtD
Isoniazid—Discomfort—Doxorubicin—kidney cancer	0.000187	0.00123	CcSEcCtD
Isoniazid—Vomiting—Capecitabine—kidney cancer	0.000179	0.00118	CcSEcCtD
Isoniazid—Thrombocytopenia—Doxorubicin—kidney cancer	0.000178	0.00117	CcSEcCtD
Isoniazid—Rash—Capecitabine—kidney cancer	0.000178	0.00117	CcSEcCtD
Isoniazid—Anorexia—Doxorubicin—kidney cancer	0.000173	0.00114	CcSEcCtD
Isoniazid—Nausea—Capecitabine—kidney cancer	0.000167	0.0011	CcSEcCtD
Isoniazid—Paraesthesia—Doxorubicin—kidney cancer	0.000163	0.00107	CcSEcCtD
Isoniazid—Dyspepsia—Doxorubicin—kidney cancer	0.00016	0.00105	CcSEcCtD
Isoniazid—Decreased appetite—Doxorubicin—kidney cancer	0.000158	0.00104	CcSEcCtD
Isoniazid—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000157	0.00103	CcSEcCtD
Isoniazid—Fatigue—Doxorubicin—kidney cancer	0.000156	0.00103	CcSEcCtD
Isoniazid—Feeling abnormal—Doxorubicin—kidney cancer	0.00015	0.000982	CcSEcCtD
Isoniazid—Body temperature increased—Doxorubicin—kidney cancer	0.000143	0.000942	CcSEcCtD
Isoniazid—Hypersensitivity—Doxorubicin—kidney cancer	0.000134	0.000878	CcSEcCtD
Isoniazid—Asthenia—Doxorubicin—kidney cancer	0.00013	0.000855	CcSEcCtD
Isoniazid—Vomiting—Doxorubicin—kidney cancer	0.000115	0.000758	CcSEcCtD
Isoniazid—Rash—Doxorubicin—kidney cancer	0.000114	0.000752	CcSEcCtD
Isoniazid—Nausea—Doxorubicin—kidney cancer	0.000108	0.000708	CcSEcCtD
Isoniazid—CYP2C19—Metabolism—FH—kidney cancer	2.92e-05	0.000398	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—APRT—kidney cancer	2.92e-05	0.000398	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ALAD—kidney cancer	2.91e-05	0.000397	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PPAT—kidney cancer	2.89e-05	0.000393	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.89e-05	0.000393	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GLIPR1—kidney cancer	2.86e-05	0.00039	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PPAT—kidney cancer	2.86e-05	0.00039	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.85e-05	0.000389	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ST3GAL2—kidney cancer	2.84e-05	0.000388	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.82e-05	0.000385	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CRABP1—kidney cancer	2.82e-05	0.000384	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CCBL1—kidney cancer	2.82e-05	0.000384	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.8e-05	0.000381	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PTEN—kidney cancer	2.79e-05	0.000381	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ALDH1A1—kidney cancer	2.78e-05	0.000379	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GPC3—kidney cancer	2.74e-05	0.000374	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ACY1—kidney cancer	2.72e-05	0.000371	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—FH—kidney cancer	2.68e-05	0.000366	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—APRT—kidney cancer	2.68e-05	0.000366	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CA2—kidney cancer	2.67e-05	0.000364	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PGK1—kidney cancer	2.66e-05	0.000363	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SLC5A3—kidney cancer	2.66e-05	0.000363	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—APRT—kidney cancer	2.66e-05	0.000363	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—FH—kidney cancer	2.66e-05	0.000363	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ITPR2—kidney cancer	2.62e-05	0.000357	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CA9—kidney cancer	2.62e-05	0.000357	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—LDHB—kidney cancer	2.61e-05	0.000356	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ALAD—kidney cancer	2.6e-05	0.000354	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.6e-05	0.000354	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.55e-05	0.000348	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ST3GAL2—kidney cancer	2.54e-05	0.000346	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GPC3—kidney cancer	2.52e-05	0.000344	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GPC3—kidney cancer	2.5e-05	0.000341	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ALDH1A1—kidney cancer	2.48e-05	0.000338	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CA2—kidney cancer	2.45e-05	0.000335	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GLIPR1—kidney cancer	2.44e-05	0.000333	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PPAT—kidney cancer	2.44e-05	0.000333	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CA2—kidney cancer	2.43e-05	0.000332	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.41e-05	0.000329	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALAD—kidney cancer	2.39e-05	0.000326	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTT1—kidney cancer	2.39e-05	0.000326	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ACHE—kidney cancer	2.39e-05	0.000326	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.39e-05	0.000326	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PGK1—kidney cancer	2.38e-05	0.000324	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SLC5A3—kidney cancer	2.38e-05	0.000324	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALAD—kidney cancer	2.37e-05	0.000323	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.33e-05	0.000318	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—LDHB—kidney cancer	2.33e-05	0.000318	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PDHB—kidney cancer	2.31e-05	0.000316	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.31e-05	0.000315	CbGpPWpGaD
Isoniazid—CYP3A4—Biological oxidations—POMC—kidney cancer	2.31e-05	0.000315	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.28e-05	0.000311	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—APRT—kidney cancer	2.27e-05	0.00031	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—FH—kidney cancer	2.27e-05	0.00031	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CA9—kidney cancer	2.27e-05	0.000309	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—SCARB1—kidney cancer	2.26e-05	0.000309	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.26e-05	0.000308	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS1—kidney cancer	2.24e-05	0.000305	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CRABP1—kidney cancer	2.23e-05	0.000304	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.22e-05	0.000303	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.21e-05	0.000302	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PSMD7—kidney cancer	2.2e-05	0.0003	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PGK1—kidney cancer	2.19e-05	0.000298	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC5A3—kidney cancer	2.19e-05	0.000298	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CCBL1—kidney cancer	2.18e-05	0.000297	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PGK1—kidney cancer	2.17e-05	0.000296	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.17e-05	0.000296	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—LDHB—kidney cancer	2.14e-05	0.000292	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GPC3—kidney cancer	2.14e-05	0.000291	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—LDHB—kidney cancer	2.13e-05	0.00029	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—BCHE—kidney cancer	2.08e-05	0.000284	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CA2—kidney cancer	2.08e-05	0.000283	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ITPR2—kidney cancer	2.07e-05	0.000282	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—SLC5A5—kidney cancer	2.06e-05	0.00028	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALAD—kidney cancer	2.03e-05	0.000276	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CA9—kidney cancer	2.02e-05	0.000276	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—SLC2A1—kidney cancer	1.99e-05	0.000271	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.98e-05	0.00027	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.98e-05	0.000269	CbGpPWpGaD
Isoniazid—NAT2—Metabolism—PIK3CA—kidney cancer	1.97e-05	0.000268	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.93e-05	0.000264	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CRABP1—kidney cancer	1.93e-05	0.000263	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTT1—kidney cancer	1.89e-05	0.000258	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ACHE—kidney cancer	1.89e-05	0.000258	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.89e-05	0.000257	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PPAT—kidney cancer	1.89e-05	0.000257	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CA9—kidney cancer	1.86e-05	0.000254	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PGK1—kidney cancer	1.85e-05	0.000253	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.85e-05	0.000253	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CA9—kidney cancer	1.84e-05	0.000251	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—LDHB—kidney cancer	1.82e-05	0.000248	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.8e-05	0.000246	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ITPR2—kidney cancer	1.79e-05	0.000244	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—SCARB1—kidney cancer	1.79e-05	0.000244	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS1—kidney cancer	1.77e-05	0.000241	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—APRT—kidney cancer	1.75e-05	0.000239	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—FH—kidney cancer	1.75e-05	0.000239	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PSMD7—kidney cancer	1.74e-05	0.000237	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CRABP1—kidney cancer	1.72e-05	0.000234	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTP1—kidney cancer	1.66e-05	0.000226	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.65e-05	0.000225	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GPC3—kidney cancer	1.65e-05	0.000225	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—BCHE—kidney cancer	1.65e-05	0.000224	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTT1—kidney cancer	1.63e-05	0.000223	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ACHE—kidney cancer	1.63e-05	0.000223	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—SLC5A5—kidney cancer	1.63e-05	0.000222	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CA2—kidney cancer	1.6e-05	0.000219	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ITPR2—kidney cancer	1.6e-05	0.000218	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CRABP1—kidney cancer	1.58e-05	0.000216	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CA9—kidney cancer	1.58e-05	0.000215	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—SLC2A1—kidney cancer	1.57e-05	0.000214	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—ABCB1—kidney cancer	1.57e-05	0.000214	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CRABP1—kidney cancer	1.57e-05	0.000214	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALAD—kidney cancer	1.56e-05	0.000213	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SCARB1—kidney cancer	1.55e-05	0.000211	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.54e-05	0.00021	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS1—kidney cancer	1.53e-05	0.000209	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.53e-05	0.000208	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—GSTM1—kidney cancer	1.52e-05	0.000208	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PSMD7—kidney cancer	1.5e-05	0.000205	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.49e-05	0.000203	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.47e-05	0.000201	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ITPR2—kidney cancer	1.47e-05	0.0002	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTT1—kidney cancer	1.46e-05	0.000199	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ACHE—kidney cancer	1.46e-05	0.000199	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ITPR2—kidney cancer	1.46e-05	0.000199	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—CYP1A1—kidney cancer	1.44e-05	0.000197	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PGK1—kidney cancer	1.43e-05	0.000195	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.43e-05	0.000195	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—BCHE—kidney cancer	1.42e-05	0.000194	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SLC5A5—kidney cancer	1.41e-05	0.000192	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—LDHB—kidney cancer	1.4e-05	0.000191	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SCARB1—kidney cancer	1.38e-05	0.000188	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS1—kidney cancer	1.37e-05	0.000186	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—SLC2A1—kidney cancer	1.36e-05	0.000185	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.34e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ACHE—kidney cancer	1.34e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTT1—kidney cancer	1.34e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CRABP1—kidney cancer	1.34e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PSMD7—kidney cancer	1.34e-05	0.000183	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ACHE—kidney cancer	1.33e-05	0.000181	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTT1—kidney cancer	1.33e-05	0.000181	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.32e-05	0.00018	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTP1—kidney cancer	1.31e-05	0.000179	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—BCHE—kidney cancer	1.27e-05	0.000173	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SCARB1—kidney cancer	1.27e-05	0.000173	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SCARB1—kidney cancer	1.26e-05	0.000172	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS1—kidney cancer	1.26e-05	0.000171	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.25e-05	0.000171	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ITPR2—kidney cancer	1.25e-05	0.00017	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS1—kidney cancer	1.25e-05	0.00017	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—ABCB1—kidney cancer	1.24e-05	0.000169	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PSMD7—kidney cancer	1.23e-05	0.000168	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PSMD7—kidney cancer	1.22e-05	0.000167	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CA9—kidney cancer	1.22e-05	0.000166	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.21e-05	0.000165	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—GSTM1—kidney cancer	1.2e-05	0.000164	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.18e-05	0.00016	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—BCHE—kidney cancer	1.17e-05	0.000159	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—BCHE—kidney cancer	1.16e-05	0.000158	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.15e-05	0.000157	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.15e-05	0.000157	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.15e-05	0.000157	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.14e-05	0.000156	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.14e-05	0.000156	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTT1—kidney cancer	1.14e-05	0.000155	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ACHE—kidney cancer	1.14e-05	0.000155	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTP1—kidney cancer	1.13e-05	0.000154	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.11e-05	0.000152	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.1e-05	0.000151	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—POMC—kidney cancer	1.08e-05	0.000147	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SCARB1—kidney cancer	1.08e-05	0.000147	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.07e-05	0.000146	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—ABCB1—kidney cancer	1.07e-05	0.000146	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS1—kidney cancer	1.06e-05	0.000145	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PSMD7—kidney cancer	1.04e-05	0.000142	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—GSTM1—kidney cancer	1.04e-05	0.000142	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CRABP1—kidney cancer	1.03e-05	0.000141	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.02e-05	0.00014	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTP1—kidney cancer	1.01e-05	0.000138	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—BCHE—kidney cancer	9.89e-06	0.000135	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—CYP1A1—kidney cancer	9.86e-06	0.000134	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC5A5—kidney cancer	9.77e-06	0.000133	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ITPR2—kidney cancer	9.61e-06	0.000131	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—ABCB1—kidney cancer	9.56e-06	0.00013	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—SLC2A1—kidney cancer	9.44e-06	0.000129	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.35e-06	0.000127	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTP1—kidney cancer	9.29e-06	0.000127	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—GSTM1—kidney cancer	9.28e-06	0.000127	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTP1—kidney cancer	9.21e-06	0.000126	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	9.16e-06	0.000125	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—CYP1A1—kidney cancer	8.8e-06	0.00012	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—ABCB1—kidney cancer	8.8e-06	0.00012	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTT1—kidney cancer	8.76e-06	0.00012	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ACHE—kidney cancer	8.76e-06	0.00012	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—ABCB1—kidney cancer	8.72e-06	0.000119	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTGS2—kidney cancer	8.58e-06	0.000117	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—GSTM1—kidney cancer	8.54e-06	0.000116	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—POMC—kidney cancer	8.51e-06	0.000116	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—GSTM1—kidney cancer	8.47e-06	0.000115	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SCARB1—kidney cancer	8.3e-06	0.000113	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS1—kidney cancer	8.21e-06	0.000112	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.1e-06	0.00011	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—CYP1A1—kidney cancer	8.09e-06	0.00011	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PSMD7—kidney cancer	8.05e-06	0.00011	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—CYP1A1—kidney cancer	8.02e-06	0.000109	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.99e-06	0.000109	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTP1—kidney cancer	7.87e-06	0.000107	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—BCHE—kidney cancer	7.64e-06	0.000104	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.54e-06	0.000103	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PTEN—kidney cancer	7.49e-06	0.000102	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—ABCB1—kidney cancer	7.45e-06	0.000102	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—POMC—kidney cancer	7.35e-06	0.0001	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.28e-06	9.93e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—GSTM1—kidney cancer	7.23e-06	9.86e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.23e-06	9.86e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—CYP1A1—kidney cancer	6.86e-06	9.35e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTGS2—kidney cancer	6.78e-06	9.25e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.59e-06	8.99e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—POMC—kidney cancer	6.56e-06	8.95e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTP1—kidney cancer	6.08e-06	8.28e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—POMC—kidney cancer	6.04e-06	8.23e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—POMC—kidney cancer	5.98e-06	8.16e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PTEN—kidney cancer	5.92e-06	8.07e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTGS2—kidney cancer	5.86e-06	7.99e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—ABCB1—kidney cancer	5.75e-06	7.84e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.63e-06	7.68e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—GSTM1—kidney cancer	5.58e-06	7.61e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.29e-06	7.22e-05	CbGpPWpGaD
Isoniazid—CYP2A6—Metabolism—PIK3CA—kidney cancer	5.28e-06	7.2e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTGS2—kidney cancer	5.23e-06	7.14e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PTEN—kidney cancer	5.11e-06	6.97e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—POMC—kidney cancer	5.11e-06	6.97e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTGS2—kidney cancer	4.81e-06	6.56e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTGS2—kidney cancer	4.77e-06	6.51e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PTEN—kidney cancer	4.56e-06	6.22e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PTEN—kidney cancer	4.2e-06	5.72e-05	CbGpPWpGaD
Isoniazid—CYP2E1—Metabolism—PIK3CA—kidney cancer	4.17e-06	5.69e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PTEN—kidney cancer	4.16e-06	5.67e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTGS2—kidney cancer	4.08e-06	5.56e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—POMC—kidney cancer	3.95e-06	5.38e-05	CbGpPWpGaD
Isoniazid—CYP2C8—Metabolism—PIK3CA—kidney cancer	3.61e-06	4.92e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PTEN—kidney cancer	3.56e-06	4.85e-05	CbGpPWpGaD
Isoniazid—CYP2C19—Metabolism—PIK3CA—kidney cancer	3.22e-06	4.39e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTGS2—kidney cancer	3.15e-06	4.29e-05	CbGpPWpGaD
Isoniazid—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.96e-06	4.04e-05	CbGpPWpGaD
Isoniazid—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.94e-06	4e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PTEN—kidney cancer	2.74e-06	3.74e-05	CbGpPWpGaD
Isoniazid—CYP1A2—Metabolism—PIK3CA—kidney cancer	2.51e-06	3.42e-05	CbGpPWpGaD
Isoniazid—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.94e-06	2.64e-05	CbGpPWpGaD
